WO2009145576A2 - Aldohexose épimérase et procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci - Google Patents

Aldohexose épimérase et procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci Download PDF

Info

Publication number
WO2009145576A2
WO2009145576A2 PCT/KR2009/002840 KR2009002840W WO2009145576A2 WO 2009145576 A2 WO2009145576 A2 WO 2009145576A2 KR 2009002840 W KR2009002840 W KR 2009002840W WO 2009145576 A2 WO2009145576 A2 WO 2009145576A2
Authority
WO
WIPO (PCT)
Prior art keywords
aldohexose
epimerase
galactose
udp
glucose
Prior art date
Application number
PCT/KR2009/002840
Other languages
English (en)
Korean (ko)
Other versions
WO2009145576A3 (fr
Inventor
김필
엄태국
Original Assignee
주식회사 삼양제넥스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 삼양제넥스 filed Critical 주식회사 삼양제넥스
Publication of WO2009145576A2 publication Critical patent/WO2009145576A2/fr
Publication of WO2009145576A3 publication Critical patent/WO2009145576A3/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/02—Monosaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose

Definitions

  • the present invention relates to aldohexose epimerase, an enzymatic preparation method of aldohexose epimer using the same, and a screening method of aldohexose epimerase. More specifically, the present invention treats an aldohexose epimer by treating an aldohexose such as glucose with an epimerase such as a modified aldohexose epimerase obtained by directional molecular evolution of the wild type UDP-galactose 4-epimerase. It relates to a method for producing enzymatically and a method for screening epimerase enzyme by measuring the activity of aldohexose epimerase.
  • isomerization enzymes of sugars derived from various kinds of microorganisms are actively studied for industrial use.
  • xylose isomerase mainly used in the preparation of high fructose syrup and arabinose isomerase capable of producing tagatose, which is emerging as a functional substitute sweetener
  • the industrial potential of these enzymes is that they can catalyze the interconversion of sugars in addition to the native substrates of xylose and arabinose.
  • general properties of enzymes namely limited substrate specificity and affinity, optimal conditions, etc., are known to be a problem that must be overcome in terms of industrial applications of enzymes.
  • aldohexose epimerases present in nature include UDP-galactose-4-epimerase (EC 5.1.3.2), an epimerizing enzyme of E. coli-derived nucleic acid active substrates.
  • the catalytic site directly involved in the enzymatic activity has a space to recognize UDP to recognize UDP-galactose or UDP-glucose as a substrate and to convert the recognized substrate into UDP-glucose or UDP-galactose. Catalyzes the merization reaction.
  • This natural aldohex epimerase uses only UDP-aldohexose, which is an aldohexose activated form of UDP, as a substrate.
  • aldohexose is used as a substrate.
  • the step of converting to active form and converting UDP-aldohexose which is a product by epimerization back to aldohexose are additionally required.
  • an epimerase enzyme that recognizes aldohexose itself, which is not UDP-active, as a substrate and produces epimer aldohexose
  • food and pharmaceuticals can be efficiently and inexpensively reduced by drastically reducing the additional steps described above.
  • Alohexose used as a raw material can be obtained.
  • epimerase enzymes capable of epimerizing aldohexose itself have not been developed, and in particular, there is no known method for enzymatically preparing galactose, which is a raw material of tagatose, a high value added saccharide from glucose. not.
  • the general method of preparing aldohexose having high added value has a problem of complicated process such as using expensive raw materials or obtaining specific mutants recognized by enzymes present in nature. Therefore, the present inventors have provided an economical method for producing high value-added epimer type aldohexose from low-cost aldohexose as a raw material, for example, an enzymatic method for producing galactose from glucose, thereby providing high-value sugars at low cost. It is intended to enable efficient production.
  • the present invention does not go through a cumbersome process such as converting an inexpensive aldohexose raw material such as glucose into a UDP-active form, and converts the raw material itself into a relatively high value added monosaccharide such as galactose by treating the raw material with an epimerase enzyme.
  • a method for enzymatic preparation of a hexose epimer is provided.
  • the present invention recognizes aldohexose itself, such as glucose, which is not UDP-active, as a substrate by directional molecular evolution of UDP-galactose 4-epimerase, and as its epimer having higher utility by epimerization of the substrate.
  • novel aldohexose epimerases that can be converted.
  • the present invention also measures the amount of NADH produced after reacting a microbial cell lysate of interest with a reaction solution comprising glucose, NAD + , and ⁇ -galactose dehydrogenase, and measuring the amount of wild type UDP-galactose 4- Selecting microorganisms having aldohexose epimerase activity as compared to the amount of NADH produced in the reaction by lysate of control cells with epimerase gene, and obtaining aldohexose epimerase therefrom.
  • the present invention it is possible to provide a simple method for enzymatic preparation of an aldohexose epimer which can convert aldohexose into a relatively high value aldohexose epimer.
  • the present invention also provides an aldohexose epimerase that performs epimerization of aldohexose, such as aldohexose epimerase, for example, by directional molecular evolution, thereby enzymatic preparation of epimeric aldohexose. It can be useful for.
  • the present invention provides a method for screening aldohexose epimerase, so that it is possible to efficiently select industrially useful aldohex epimerase.
  • FIG. 1 schematically shows the evolution of UDP-galactose 4-epimerase (epimerase A) to aldohexose epimerase (epimerase B).
  • FIG. 2 is an HPLC result showing the conversion efficiency of galactose from glucose by aldohexose epimerase selected according to the example.
  • (a) is an HPLC chromatogram of glucose and galactose standards
  • (b) is an HPLC chromatogram showing peaks of galactose detected in the reaction solution by aldohexose epimerase selected according to an embodiment of the present invention.
  • 3 is a graph showing the pH-dependent activity of aldohexose epimerase selected according to an embodiment of the present invention.
  • Figure 4 is a graph showing the activity according to the temperature of aldohexose epimerase selected in accordance with an embodiment of the present invention.
  • UDP-galactose 4-epimerase is understood to refer to an enzyme that recognizes UDP-galactose or UDP-glucose as a substrate and catalyzes epimerization between them.
  • aldohexose refers to any D-aldohexose or L-aldohex that is naturally present or synthesized, such as glucose, allose, altrose, mannose, gulose, idose, galactose, talos. It is interpreted to include a source.
  • aldohexose epimerase refers to an aldohexose such as glucose, allose, altrose, mannose, gulose, idose, galactose, and talos as a substrate to be subjected to epimerization at any carbon position.
  • Enzymes that can be converted into its epimeric type aldohexose by the present invention include all mutated or naturally occurring enzymes, including aldohexose 3-epimerase, aldohexose 4-epimerase and the like. It is interpreted as.
  • the substrate of the aldohexose epimerase may be D-aldohexose or L-aldohexose.
  • One aspect of the present invention is to provide a method for enzymatic preparation of an aldohexose epimer, comprising the step of obtaining an aldohexose epimer by subjecting the aldohexose to an epimerase enzyme to epimerize it.
  • the aldohexose substrate treated with the epimerase enzyme is D-aldohexose or L- selected from the group consisting of glucose, allose, altrose, mannose, gulose, idose, galactose and talos.
  • Aldohexose preferably glucose, most preferably D-glucose.
  • high value-added monosaccharides such as galactose can be prepared by a simple epimerase enzyme treatment process without converting aldohexose such as glucose to UDP-active type.
  • aldohexose epimers can be prepared by treating aldohexose with an epimerase enzyme to C-3 epimerization or C-4 epimerization, preferably C-4 epimerization.
  • the epimerase enzyme treatment is carried out at pH 7 to 10 and at a temperature of 30 to 50 ° C., preferably at pH 8 to 10 and at a temperature of 35 to 40 ° C., most preferably. Is carried out at pH 8.6 and at a temperature of 37 ° C. If the pH is lower than 7 or higher than 10 during enzyme treatment, enzyme degeneration of epimerase may be induced, thereby lowering enzyme activity. In addition, if the temperature is lower than 30 °C the activity of the enzyme is too low, there is a problem that the process is inefficient, if it is higher than 50 °C there is a problem that the protein structure of the enzyme is rapidly changed to show little enzyme activity.
  • the epimerase enzyme according to the present invention is not particularly limited as long as it is an enzyme capable of converting aldohexose into its epimer, and includes all naturally occurring enzymes or enzymes mutated by aromatic molecular evolution.
  • the aldohexose epimerase obtained by directional molecular evolution of the wild type UDP-galactose 4-epimerase.
  • Another aspect of the present invention is to provide an aldohexose epimerase which performs epimerization of aldohexose, preferably epimerization at the carbon position 4.
  • the aldohexose epimerase according to the present invention is not particularly limited as long as it is an enzyme that performs epimerization of aldohexose, and includes enzymes naturally modified by enzymes or aromatic molecular evolution.
  • the aldohexose epimerase obtained by directional molecular evolution of the wild type UDP-galactose 4-epimerase, more preferably aldohexose epimerase having the amino acid sequence of SEQ ID NO: 3.
  • the method of directing directional molecular evolution of wild-type UDP-galactose 4-epimerase is not particularly limited, for example, to a mutagen such as error-prone PCR, chemicals or UV. Treatment, use of mutagenic host cells, or DNA shuffling.
  • Another aspect of the invention comprises the steps of (a) culturing and lysing the microorganism of interest to obtain a microbial cell lysate; And (b) reacting the cell lysate with a reaction solution comprising glucose, NAD + , and ⁇ -galactose dehydrogenase, and measuring the amount of NADH produced, which is then determined using wild type UDP-galactose 4-epimerase. Screening of aldohexose epimerase comprising selecting a microorganism having aldohexose epimerase activity and obtaining aldohexose epimerase therefrom compared to the amount of NADH produced by the control cell lysate having Provide a method.
  • step (a) is a step of obtaining a cell lysate of the microorganism of interest.
  • the microorganism of interest here is not particularly limited as long as the microorganism is expected to have aldohexose epimerase activity, and the microorganism into which the mutated UDP-galactose 4-epimerase gene is introduced or UDP-galactose 4-epi according to the present invention. It may be a microorganism obtained by mutating a microorganism having a merase gene.
  • the gene encoding the mutated UDP-galactose 4-epimerase may be one obtained by artificial mutation of the wild type UDP-galactose 4-epimerase gene or as a result of natural mutation.
  • wild-type UDP-galactose 4-epimerase genes can be used as a template to perform error-prone PCR, treatment with chemicals or mutagens such as UV, DNA shuffling, or the like.
  • the mutated UDP-galactose 4-epimerase gene can be obtained.
  • the mutated UDP-galactose 4-epimerase gene is obtained in vitro and then introduced into the microorganism by a conventional method such as transformation, or a mutant material treatment or homology to a microorganism having a wild-type gene. It may be obtained in microbial cells by applying a technique such as recombination.
  • the mutated UDP-galactose 4-epimerase gene may be transformed into a microorganism in the form of a single or a plurality of mutant genes.
  • a microbial population comprising a plurality of different variant genes may be formed.
  • the microorganism includes prokaryotic and eukaryotic cells, preferably prokaryotic cells.
  • prokaryotic cells preferably prokaryotic cells.
  • E. coli E. coli.
  • the microorganism to be screened is transfected with a UDP-galactose 4-epimerase variant gene library obtained by mutation-induced PCR of a gene encoding a wild type UDP-galactose 4-epimerase into a template.
  • Converted microorganisms preferably E. coli.
  • the UDP-galactose epimerase variant library is composed of variants of wild type UDP-galactose 4-epimerase.
  • the wild type UDP-galactose 4-epimerase may have a nucleotide sequence of SEQ ID NO: 2 derived from E. coli K-12 W3110.
  • Wild type UDP-galactose 4-epimerase (EC 5.1.3.2) has a portion that accommodates UDP at the active site as shown in FIG. 1, but variants selected by directional molecular evolution in accordance with the present invention are UDP Glucose is recognized as a substrate and does not have a recognized site and is converted to galactose.
  • step (b) is carried out by adding the microbial cell lysate obtained in step (a) to a reaction solution containing glucose, NAD + , and ⁇ -galactose dehydrogenase.
  • Aldohexose 4-epimerase activity was measured after addition and the amount of NADH produced was measured and compared to the amount of NADH produced in the reaction with the lysate of control cells with wild type UDP-galactose 4-epimerase. It is to select a microorganism having a.
  • the amount of NADH measured from the microbial cells to be screened in the reaction is increased compared to the control cells, the microbial sample is determined to have aldohexose epimerase activity.
  • the activity of aldohexose epimerase is obtained by adding cell lysate to the reaction solution containing glucose, NAD + , and ⁇ -galactose dehydrogenase, thereby converting glucose into galactose and subsequent galactose. It is assessed by measuring the amount of NADH produced through dehydrogenation of. The amount of NADH can be measured via absorbance at 340 nm.
  • the cell concentration before preparation of the cell lysate used as a source of aldohex epimerase was determined by measurement of absorbance at 600 nm, and the absorbance per unit cell was calculated to estimate specific activity. Can be.
  • aldohexose epimerase activity measured from microbial cells is higher than control compared to aldohexose epimerase activity measured from control microbial cells with wild type UDP-galactose 4-epimerase.
  • the microbial cells showing activity are selected to have variants of UDP-galactose 4-epimerase evolved into aldohexose epimerase.
  • by culturing the microorganisms selected to have aldohexose epimerase activity to purify the aldohexose epimerase, or directly to the source of aldohexose epimerase It can also be used.
  • the present invention also provides aldohexose epimerase obtained by the screening method of the present invention.
  • the aldohexose epimerase may be a glucose epimerase, most preferably glucose 4-epimerase, having a particularly high substrate specificity for glucose.
  • the aldohexose epimerase may have the amino acid sequence of SEQ ID NO: 3.
  • the aldohexose epimerase may be encoded by the nucleotide sequence of SEQ ID NO.
  • the aldohexose epimerase having the amino acid sequence represented by SEQ ID NO: 3 is mutated to Val of Met No. 1 and Arg of 313 compared to the amino acid sequence of UDP-galactose 4-epimerase of the wild type E. coli strain (SEQ ID NO: 1).
  • a nucleotide sequence of SEQ ID NO: 4, wherein the base sequence of SEQ ID NO: 4 is replaced with A of G and 937 C, relative to the nucleotide sequence (SEQ ID NO: 2) of the gene encoding UDP-galactose 4 epimerase of the wild type E. coli strain Substitution with G is included.
  • the aldohexose epimerase is obtained by molecular evolution of UDP-galactose 4 epimerase and the activity assessed by the production of galactose from glucose is 0.02 of wild type UDP-galactose 4 epimerase. mmole / min. 0.1 to 1 mmole / min. mg protein, compared to less than mg protein.
  • the invention also provides a recombinant vector comprising a polynucleotide encoding an aldohexose epimerase according to the invention.
  • vector refers to a DNA construct comprising a DNA sequence operably linked to a suitable regulatory sequence capable of expressing DNA in a suitable host.
  • Vectors can be plasmids, phage particles, or potential genomic inserts. Once introduced into a suitable host by transformation, the vector can replicate and function independently of the host genome, or can be integrated into the genome.
  • the invention also provides a transformed microorganism obtained by introducing a recombinant vector comprising a polynucleotide encoding an aldohexose epimerase into a host cell selected from the group consisting of bacteria, yeast and fungi.
  • the transforming microorganism may preferably be transformed E. coli.
  • the present invention also cultures a microorganism transformed by a recombinant vector comprising a polynucleotide encoding an aldohexose epimerase, and isolates the aldohexose epimerase from the cultured microorganism or culture medium to aldohexose.
  • a recombinant vector comprising a polynucleotide encoding an aldohexose epimerase, and isolates the aldohexose epimerase from the cultured microorganism or culture medium to aldohexose.
  • the present invention is also directed to epidermalization from aldohexose using an aldohexose epimerase selected by the screening method according to the invention or an enzyme capable of epimerizing aldohexose among naturally occurring enzymes.
  • an aldohexose epimerase selected by the screening method according to the invention or an enzyme capable of epimerizing aldohexose among naturally occurring enzymes.
  • aldohexose epimerase is a form isolated by purification from strain culture selected as having aldohexose epimerase activity by molecular evolution or the cultured strain or strain It may be in the form of a solution of.
  • the aldohexose epimerase may have an amino acid sequence of SEQ ID NO: 3.
  • the epimerization reaction by aldohexose epimerase is carried out at a pH of 7 to 10 and a temperature of 30 to 50 ° C, preferably of a pH of 8 to 10 and a temperature of 35 to 40 ° C. Most preferably at a pH of 8.6 and a temperature of 37 ° C.
  • Mutation-induced PCR using the primers of SEQ ID NOS: 5 and 6 and the Random mutagenesis kit (CloneTech Co.) with a template of the gene galE (SEQ ID NO: 2) encoding UDP-galactose 4-epimerase of E. coli K-12 W3110 was performed to amplify the mutated galE gene at a frequency of about 2.5 mutations / kb.
  • the PCR reaction was performed 25 cycles consisting of 1 minute denaturation at 95 ° C., 30 seconds annealing at 60 ° C. and 1 minute elongation at 72 ° C.
  • the PCR product was treated with the restriction enzymes NcoI and XbaI and ligated to pTrc99A (GenBank U13872, AP Biotech. Co.) treated with the same restriction enzyme to prepare a recombinant vector.
  • the recombinant vector was mixed with competent E. coli DH5 ⁇ prepared for transformation, and the vector was introduced by applying a current for 5 seconds under a voltage of 2.5 kV with an electroporator (Gene Pulser, Bio-Rad). Transformed Escherichia coli was prepared and transformed Escherichia coli was selected by smearing in LB medium containing 20 ⁇ g / ml ampicillin. Thus, the recombinant vector was introduced into E. coli DH5 ⁇ to prepare a gene library consisting of variants of the mutated UDP-galactose 4-epimerase gene.
  • aldohexose 4-epimerase activity of aldohexose 4-epimerase was screened for screening for aldohexose 4-epimerase from the UDP-galactose 4-epimerase variant library prepared in Example 1.
  • E. coli DH5 ⁇ from the library prepared in Example 1 was plated in LB (Luria Bertani) plate medium containing ampicillin (20 ⁇ g / mL) and incubated at 37 ° C. for 16 hours to obtain colonies. The obtained colonies were transferred to a master plate and used for measuring enzymatic activity as follows.
  • Buffer A (20 ⁇ l 10 mM glucose + 0.3 mM NAD + 20 ⁇ l + ⁇ -galactose dehydrogenase (0.35U) 1 ⁇ l + Tris-HCl (50 mM, pH 8.6) 109 ⁇ l) was added.
  • Absorbance (A2) was measured at 340 nm.
  • absorbance (A3) was measured again at 340 nm, and from this, the activity per cell per unit time of aldohexose 4-epimerase was determined as (A3-A2) / A1 / 20. Calculated in minutes.
  • Aldohexose 4-epimerase activity was measured in 940 colonies as described above, and clones showing higher activity than the control group were selected as compared to the activity obtained from the control group consisting of E. coli DH5 ⁇ containing wild type galE. .
  • Dog clones were selected. The highest activity by the selected clones was 1 mmole galactose / min.mg protein.
  • Colonies selected in Example 2 were suspended in lysis buffer (Triton-X100 0.05 mM) to obtain cell lysates containing crude enzyme.
  • the cell lysate was added to a 30 mM glucose solution in Tris-HCl (pH 8.6) to 10% (v / v), and the prepared reaction solution was placed in a 1 mL vial and maintained at 37 ° C for 30 minutes. Thereafter, the vial was put on ice to stop the reaction. 10 ⁇ l of the reaction solution was injected into HPLC (Waters) equipped with an Aminex-87P column (Bio-Rad) and a refractive index (RI) detector. In the HPLC analysis, distilled water, which is a mobile phase, was flowed at a rate of 0.6 ml / min, and the column temperature was maintained at 85 ° C. to obtain a chromatogram as shown in FIG. 2.
  • Example 2 Of the clones selected in Example 2, three of the highest activity were selected and the aldohexose 4-epimerase was separated therefrom, and the base sequence and amino acid sequence were analyzed. As a result, the amino acid sequence and base sequence of the aldohexose 4-epimerase isolated from the strain showing the highest activity were identified by SEQ ID NO: 3 and 4, respectively.
  • the amino acid sequence of SEQ ID NO: 3 confirmed in the present Example is a variation of Met No. 1 to Val and 313 Arg to Gly compared to the amino acid sequence of UDP-galactose 4-epimerase of the wild type E. coli strain (SEQ ID NO: 1)
  • the nucleotide sequence of SEQ ID NO: 4 is replaced with G of No. 1 A and G of 937 C with respect to the nucleotide sequence (SEQ ID NO: 2) of the gene encoding UDP-galactose 4 epimerase of the wild type E. coli strain Included.
  • Example 2 Three clones showing the highest activity among the clones selected in Example 2 were selected to determine the optimal pH for the activity of the aldohexose 4-epimerase.
  • the measurement of aldohexose 4-epimerase activity was carried out by the method described in Example 2 except that the buffer was changed depending on pH. 50 mM phosphate-NaOH buffer at pH 7-8, 50 mM Tris-HCl at pH 8-9 and 50 mM borate-NaOH buffer at pH 9-10 were used. Specifically, 1 mM of the reaction solution was prepared by adding 50 mM glucose and 10% (v / v) of the enzyme solution derived from the clones selected above to each pH buffer to induce an epimerization reaction, and then in the reaction solution. 100 ⁇ l was mixed with 900 ⁇ l pH 8.6 Tris-HCl buffer, NAD + , 1 unit of galactose dehydrogenase to determine the amount of galactose formed in the reaction solution.
  • clone 1 black circle
  • clone 2 square
  • Clone 3 triangle
  • Galactose one of relatively high value added monosaccharides, can be prepared by decomposing expensive raw materials, lactose, which are generally components of milk. Theoretically, it is possible to prepare UDP-galactose by using UDP-galactose epimerase by attaching UDP to glucose and then removing UDP.
  • this method has a disadvantage in that the process of attaching and detaching the UDP is very cumbersome, and the use of expensive UDP increases the process cost, making it difficult to realize in reality.
  • a method of preparing aldohexose is complicated, such as using an expensive raw material or obtaining a specific variant that can be recognized by an enzyme present in nature.
  • the present invention provides an economical method for producing high value-added epimeric aldohexose from inexpensive aldohexose, for example, an enzymatic method for producing galactose from glucose, thereby providing high value sugars at low cost.
  • Industrial utility is very high because it can be produced.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une aldohexose épimérase, un procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci, ainsi qu'un procédé de criblage d'aldohexose épimérase.
PCT/KR2009/002840 2008-05-30 2009-05-28 Aldohexose épimérase et procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci WO2009145576A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0051104 2008-05-30
KR20080051104 2008-05-30

Publications (2)

Publication Number Publication Date
WO2009145576A2 true WO2009145576A2 (fr) 2009-12-03
WO2009145576A3 WO2009145576A3 (fr) 2010-03-04

Family

ID=41377798

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/002840 WO2009145576A2 (fr) 2008-05-30 2009-05-28 Aldohexose épimérase et procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci

Country Status (2)

Country Link
KR (1) KR101057873B1 (fr)
WO (1) WO2009145576A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3006568B1 (fr) 2013-06-05 2019-08-14 Cj Cheiljedang Corporation Procédé de production de tagatose
KR101868194B1 (ko) * 2013-11-19 2018-06-18 씨제이제일제당 (주) 호열균 유래 당 에피머화효소를 포함하는, 비인산헥소오스의 에피머화용 조성물
KR20180111667A (ko) 2017-03-31 2018-10-11 씨제이제일제당 (주) 타가토스 생산용 조성물 및 이를 이용한 타가토스 제조방법
EP3604514A4 (fr) 2017-03-31 2021-01-20 Cj Cheiljedang Corporation Composition pour la production de tagatose et procédé pour la production de tagatose utilisant celle-ci
EP3604516A4 (fr) 2017-03-31 2021-01-20 Cj Cheiljedang Corporation Composition pour la production de tagatose et procédé de production de tagatose la mettant en oeuvre
CN114350646B (zh) * 2021-12-22 2023-08-29 北京理工大学 一种UDP-糖差向异构酶PsUGE2及其在合成阿拉伯糖苷中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582910B1 (en) * 1999-05-28 2003-06-24 Joseph S. Lam WbpP and method for assay of WbpP
US20060075526A1 (en) * 1999-02-10 2006-04-06 Carlson Thomas J UDP-glucose modifiers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710991D0 (en) 1997-05-28 1997-07-23 Danisco Enzyme

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060075526A1 (en) * 1999-02-10 2006-04-06 Carlson Thomas J UDP-glucose modifiers
US6582910B1 (en) * 1999-05-28 2003-06-24 Joseph S. Lam WbpP and method for assay of WbpP

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JAMES B. THODEN ET AL.: 'Crystal Structures of the Oxidized and Reduced Forms of UDP- galactose 4-Epimerase Isolated from Escherichia coli.' BIOCHEMISTRY vol. 35, 1996, pages 2557 - 2566 *
JAMES B. THODEN ET AL.: 'Molecular Structures of the S124A, S124T, and S124V Site-Direcd Mutants of UDP-galactose 4-Epimerase from Eschericia coli.' BIOCHEMISTRY vol. 36, 1997, pages 10685 - 10695 *

Also Published As

Publication number Publication date
KR20090125004A (ko) 2009-12-03
KR101057873B1 (ko) 2011-08-19
WO2009145576A3 (fr) 2010-03-04

Similar Documents

Publication Publication Date Title
WO2009145576A2 (fr) Aldohexose épimérase et procédé de préparation enzymatique d'un aldohexose épimère au moyen de celle-ci
CN112375750B (zh) 一种糖基转移酶突变体及其催化合成莱鲍迪苷a的方法
WO2010110599A2 (fr) Nouvelle α-néoagarobiose hydrolase, et procédé d'obtention d'un monosaccharide à l'aide de celle-ci
CN112159831B (zh) 一种制备烟酰胺单核苷酸的方法
CN110396508B (zh) 源自Nocardia cyriacigeorgica的L-泛解酸内酯脱氢酶及应用
KR20150076257A (ko) D-알로오스의 생산 방법
CN110699373A (zh) 尿苷二磷酸葡萄糖高产菌株及其应用
JP2022544085A (ja) プシコース３－エピメラーゼミュータント、それを発現するための遺伝子工学菌、その固定化酵素及び固定化方法
CN110396507B (zh) 源自Cnuibacter physcomitrellae的L-泛解酸内酯脱氢酶
CN106609249B (zh) 克雷伯氏肺炎杆菌突变菌及其生产1,3-丙二醇的应用
Taran et al. Enzymatic transglycosylation of natural and modified nucleosides by immobilized thermostable nucleoside phosphorylases from Geobacillus stearothermophilus
CN117535256A (zh) 一种羰基还原酶及其在玻色因合成中应用
WO2021135796A1 (fr) D-xylulose 4-épimérase, son mutant et son utilisation
US8137946B2 (en) Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same
CN112921025B (zh) 一种差向异构酶的突变体，其编码基因、氨基酸序列及其应用
CN110607335A (zh) 一种烟酰胺腺嘌呤二核苷酸类化合物生物合成方法
WO2014171635A1 (fr) D-sorbitol déshydrogénase inédite et procédé de production de l-sorbose au moyen de celle-ci
CN110396506B (zh) 源自Nocardia asteroides的L-泛解酸内酯脱氢酶及其应用
US9005937B2 (en) Dual cofactor specific ribitol dehydrogenase and use thereof
WO2018117773A2 (fr) Souche recombinée ayant une voie métabolique du sucre modifiée et procédé de criblage de sucre isomérase l'utilisant
Tan et al. Directed evolution of glycosyltransferases by a single-cell ultrahigh-throughput FACS-based screening method
CN117587086B (zh) 一种制备n1-甲基假尿苷三磷酸的方法
WO2014171636A1 (fr) Nouvelle ribitol déshydrogénase et procédé pour préparer de la l-ribulose l'utilisant
CN113462704B (zh) 一种植物细胞分裂素狭霉素的生物合成基因簇及其生物材料以及在合成狭霉素中的应用
CN116790535A (zh) 一种糖基转移酶突变体及其应用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09755041

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09755041

Country of ref document: EP

Kind code of ref document: A2